Comment
LHRH antagonists vs LHRH agonists: which is more beneficial in prostate cancer therapy?
Affiliations
- PMID: 19626831
Item in Clipboard
Comment
LHRH antagonists vs LHRH agonists: which is more beneficial in prostate cancer therapy?
Oncology (Williston Park).
2009 Jun.
No abstract available
Comment on
-
The role of LHRH antagonists in the treatment of prostate cancer.Oncology (Williston Park). 2009 Jun;23(7):626-30. Oncology (Williston Park). 2009. PMID: 19626830 Review.
Similar articles
-
The role of LHRH antagonists in the treatment of prostate cancer.Oncology (Williston Park). 2009 Jun;23(7):626-30. Oncology (Williston Park). 2009. PMID: 19626830 Review.
-
Is there a role for LHRH antagonists in prostate cancer?Oncology (Williston Park). 2009 Jun;23(7):632, 635. Oncology (Williston Park). 2009. PMID: 19626832 No abstract available.
-
Important considerations in LHRH antagonist therapy for prostate cancer.Oncology (Williston Park). 2009 Jun;23(7):636-7. Oncology (Williston Park). 2009. PMID: 19626833 No abstract available.
-
Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone.Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):157-67. doi: 10.1038/ncpendmet0399. Nat Clin Pract Endocrinol Metab. 2007. PMID: 17237842 Review.
-
Hormone therapy in prostate cancer: LHRH antagonists versus LHRH analogues.Eur Urol. 2004 Sep;46(3):279-83; discussion 283-4. doi: 10.1016/j.eururo.2004.05.006. Eur Urol. 2004. PMID: 15306097 Review.
Cited by
-
Treatment patterns and trends in patients dying of prostate cancer in Quebec: a population-based study.Curr Oncol. 2017 Aug;24(4):240-248. doi: 10.3747/co.24.3598. Epub 2017 Aug 31. Curr Oncol. 2017. PMID: 28874892 Free PMC article.
-
Drug costs in the management of metastatic castration-resistant prostate cancer in Canada.BMC Health Serv Res. 2014 Jun 13;14:252. doi: 10.1186/1472-6963-14-252. BMC Health Serv Res. 2014. PMID: 24927758 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical